• 1
    Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer (Cancer Cytopathol). 2003; 99: 97104.
  • 2
    Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst. 2001; 93: 17911798.
  • 3
    Sauter ER, Ehya H, Mammen A, Klein G. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional biopsy. Br J Cancer. 2001; 85: 19521957.
  • 4
    King BL. The promise and pitfalls of breast fluid proteins as markers for cancer detection. Cancer J. 2002; 8: 295297.
  • 5
    Klein P, Glaser E, Grogan L, et al. Biomarker assays in nipple aspirate fluid. Breast J. 2001; 7: 378387.
  • 6
    Sauter ER, Ehya H, Babb J, MacGibbon B. Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumor size. Br J Cancer. 1999; 81: 12221227.
  • 7
    Phillips HA, Howard GC, Miller WR. Pilot studies on the p53 gene in nipple aspirate fluid from patients with breast cancer. Breast Cancer Res Treat. 2000; 61: 139143.
  • 8
    Hanisch FG, Baldus SE. The Thomsen-Freidenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol Histopathol. 1997; 12: 263281.
  • 9
    Baldus SE, Hanisch FG, Monaca E, et al. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1. Histol Histopathol. 1999; 14: 11531158.
  • 10
    Shamsuddin AM, Tyner GT, Yuang GY. Common expression of the tumor marker D-galactose-β-[1[RIGHTWARDS ARROW]3]-N-acetyl-D-galactosomine by different adenocarcinomas: evidence of field effect phenomenon. Cancer Res. 1995; 55: 149152.
  • 11
    Evelegh MJ. A novel method for the quantification of galactose oxidase-Schiff's reaction and its use in cancer detection. J Clin Ligand Assay. 2002; 25: 9194.
  • 12
    American Cancer Society. Cancer facts and figures 2003. Atlanta: American Cancer Society, 2003.
  • 13
    Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997; 76: 494501.
  • 14
    O'Shaughnessy JA. Ductal lavage: clinical utility and future promise. Surg Clin North Am. 2003; 83: 753769.
  • 15
    Stein R, Chen S, Grossman W, Goldenberg DM. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res. 1989; 49: 3237.
  • 16
    Shue GL, Kawa S, Kato M, et al. Expression of glycoconjugates in pancreatic, gastric and colonic tissue by Bauhinia purpurea, Vicia villosa, and peanut lectins. Scand J Gastroenterol. 1993; 28: 599603.
  • 17
    Friedlander M, Leary J, Russel P. An evaluation of CA125, CA1, and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome. Pathology. 1988; 20: 3844.
  • 18
    Sasano H, Saito Y, Nagura H, Kudo R, Rojas M, Silverberg SG. Lectin histochemistry in mucinous and serous ovarian neoplasms. Int J Gynecol Pathol. 1991; 10: 252259.
  • 19
    Bychkov V, Doland JR, Reddy VB. Lectin binding to common epithelial tumors of the ovaries. Gynecol Obstet Invest. 1991; 31: 166171.
  • 20
    Sobrinho-Simoes M, Damjanov I. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Arch Pathol Lab Med. 1986; 110: 722729.
  • 21
    Chung YS, Yamashita Y, Kato Y, Nakata B, Sawada T, Sowa M. Prognostic significance of T antigen expression in patients with gastric carcinoma. Cancer. 1996; 77: 17681773.
  • 22
    David L, Nesland JM, Clausen H, Carneiro F, Sobrinho-Simoes M. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn, and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl. 1992; 27: 162172.
  • 23
    Cooper HS. Peanut lectin-binding sites in large bowel carcinoma. Lab Invest. 1982; 47: 383390.
  • 24
    Itzkowitz SH, Yuan M, Montgomery CK, et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989; 49: 197204.
  • 25
    Klein PJ, Osmers R, Vierbuchen M, Ortmann M, Kania J, Uhlenbruck G. The importance of lectin binding sites and carcinoembryonic antigen with regard to normal, hyperplastic, andenomatous and carcinomatous colonic mucosa. Recent Results Cancer Res. 1981; 79: 19.
  • 26
    Langkilde NC, Wolf H, Orntoft TF. Binding of wheat germ agglutinin and peanut agglutinin to human transitional cell carcinoma: correlation with histopathologic grade, invasion and DNA ploidy. Cancer. 1989; 64: 849853.
  • 27
    Yamada T, Fukui I, Yokokawa M, Oshima H. Changing expression of ABH blood group and cryptic T-antigens of non-invasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression. Cancer. 1988; 61: 721726.
  • 28
    Teshima S, Hirohashi S, Shimasato Y, et al. Histochemically demonstrable changes in cell surface carbohydrates of human germ cell tumors. Lab Invest. 1984; 50: 271277.
  • 29
    Morghen M, Carpenter F. Peanut lectin: a histochemical marker for phaeochromocytomas. Virchows Arch. 1991; 396: 313317.
  • 30
    Springer GF, Desai PR, Banatwalay I. Blood group MN antigens and precursors in normal and malignant breast glandular tissue. J Natl Cancer Inst. 1975; 54: 335339.
  • 31
    Klein PJ, Newman RA, Mueller P, et al. The presence and significance of the Thomsen-Friedenreich antigen in mammary gland. Its topochemistry in normal, hyperplastic and carcinoma tissue of the breast. J Cancer Res Clin Oncol. 1979; 93: 205214.
  • 32
    Newman RA, Klein PJ, Rudland PS. Binding of peanut lectin to breast epithelium, human carcinomas and a cultured rat mammary stem cell: use of the lectin as a marker of mammary differentiation. J Natl Cancer Inst. 1979; 63: 13391346.
  • 33
    Seitz RC, Fischer K, Stegner HE, Poschmann A. Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen. Cancer. 1984; 54: 830836.
  • 34
    Klein PJ, Vierbuchen M, Wurz H, Schulz KD, Newman RA. Secretion-associated lectin-binding sites as a parameter of hormone dependence in mammary carcinoma. Br J Cancer. 1981; 44: 746748.
  • 35
    Klein PJ, Vierbuchen M, Fischer J, Schulz KD, Farrar G, Uhlenbruck G. The significance of lectin receptors for the evaluation of hormone dependence in breast cancer. J Steroid Biochem. 1983; 19: 839844.
  • 36
    Boecker W, Klaubert A, Bahnsen J, et al. Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging and receptor status. Virchows Arch. 1984; 403: 149-161.
  • 37
    van der Linden JC, Baak JP, Lindeman J, Smeulders AW, Meyer CJ. Carcinoembryonic antigen expression and peanut agglutinin in primary breast cancer and lymph node metastases: lack of correlation with clinical, histopathological, biochemical and morphometric features. Histopathology. 1985; 9: 10511059.
  • 38
    Daxenbichler G, Duerken M, Marth C, Bock G, Dapunt O. Influence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells. J Steroid Biochem. 1986; 24: 119124.
  • 39
    Barry JD, Koch TJ, Cohen C, Brigati DJ, Sharkey FE. Correlation of immunohistochemical markers with patient prognosis in breast carcinoma. A quantitative study. Am J Clin Pathol. 1984; 82: 582585.
  • 40
    Wolf MF, Ludwig A, Fritz P, Schumacher K. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. Tumor Biol. 1988; 9: 190194.